Joseph John to Coagulase
This is a "connection" page, showing publications Joseph John has written about Coagulase.
Connection Strength
0.552
-
Drug evaluation: tefibazumab--a monoclonal antibody against staphylococcal infection. Curr Opin Mol Ther. 2006 Oct; 8(5):455-60.
Score: 0.267
-
Topoisomerase sequences of coagulase-negative staphylococcal isolates resistant to ciprofloxacin or trovafloxacin. Antimicrob Agents Chemother. 1999 Jul; 43(7):1631-7.
Score: 0.161
-
Sequence analysis of dru regions from methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococcal isolates. Microb Drug Resist. 2001; 7(1):1-12.
Score: 0.045
-
Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci: minimal effect of beta-lactamase. Antimicrob Agents Chemother. 1980 Feb; 17(2):179-83.
Score: 0.042
-
Widespread colonization of personnel at a Veterans Affairs medical center by methicillin-resistant, coagulase-negative Staphylococcus. Clin Infect Dis. 1993 Sep; 17(3):380-8.
Score: 0.027
-
Relatedness of strains of methicillin-resistant coagulase-negative Staphylococcus colonizing hospital personnel and producing bacteremias in a neonatal intensive care unit. Pediatr Infect Dis J. 1992 Nov; 11(11):935-40.
Score: 0.006
-
Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance. J Infect Dis. 1986 Aug; 154(2):349-52.
Score: 0.004